D
Inhibikase Therapeutics, Inc. IKT
$2.37 $0.010.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Total Cash And Short-Term Investments -80.73% -62.07% -62.09% -42.51% -36.57%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -26.15% -36.11% -7.99% 336.82% -27.95%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 85.32% -26.41% -75.49% -78.10% -61.08%
Total Current Assets -76.13% -60.87% -60.88% -41.69% -37.29%

Total Current Assets -76.13% -60.87% -60.88% -41.69% -37.29%
Net Property, Plant & Equipment -43.39% -38.39% -51.33% -47.70% -44.52%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets -75.52% -60.50% -60.70% -41.83% -37.44%

Total Accounts Payable 244.30% 77.76% 34.90% -43.82% -5.97%
Total Accrued Expenses 16.32% 11.12% 60.93% -5.77% -18.00%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -2.55% 2.84% 2.93% 2.95% 4.93%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 78.99% 35.55% 58.89% -6.95% -14.67%

Total Current Liabilities 78.99% 35.55% 58.89% -6.95% -14.67%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -82.93% -67.27% -56.16% -47.84%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 71.42% 29.38% 50.98% -9.54% -16.90%

Common Stock & APIC 5.16% 5.17% 1.06% 13.19% 13.16%
Retained Earnings -31.19% -31.62% -36.68% -39.75% -43.88%
Treasury Stock & Other 1,900.00% 41.18% -101.09% -99.14% -100.37%
Total Common Equity -103.53% -73.82% -73.24% -47.81% -40.25%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -103.53% -73.82% -73.24% -47.81% -40.25%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -103.53% -73.82% -73.24% -47.81% -40.25%

Weiss Ratings